Solving Cancer Together - CCTG Strategic Plan 2022-2027

Introducing the Group's new strategic direction

A vision of a future where a cancer diagnosis is no longer a burden on Canadians

Everyone has been touched by cancer either through their own journey or supporting a loved one. Despite better treatments and outcomes, the physical, emotional, and economic burden on patients, their families, and caregivers is likely to increase due to an aging population. In addition, the environment in which trials are conducted is becoming more complex. New therapies, biomarkers, and patient reported outcomes are changing the design, the type of data and the requirements for trial conduct and oversight.

The new Strategic Plan: Solving Cancer Together articulates the scientific priorities and required supporting activities that would lead the Group through to 2027. The plan was developed with input from our research leaders, investigators, patients, research staff and stakeholders. Our new scientific priorities: Understand Cancer Biology, Reduce the Cancer Burden, and Improve Cancer Care with their associated objectives and activities will lead to new advances in innovative therapies, understanding resistance, reduce the burdens of cancer, and show the value of these innovations. Please take a moment to read the Strategic Plan and then continue to follow on the #SolvingCancerTogether web page where we will celebrate our milestones and activities aligned to the new priorities, platforms and enablers.